Evidence for CCK(A) receptor involvement in the acquisition of conditioned activity produced by cocaine in rats

Brain Research

Volumn 763, Issue 1, 1997, Pages 93-102

  Josselyn, Sheena A ^a   De Cristofaro, Antonietta ^a   Vaccarino, Franco J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Cholecystokinin; Cocaine; Conditioned activity; Devazepide; L 365,260; Locomotion; Nucleus accumbens; PD 140548; Reward related learning

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; COCAINE; DEVAZEPIDE;

ARTICLE; CONDITIONING; CONTROLLED STUDY; LEARNING; LOCOMOTION; MALE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING; REWARD;

ANIMALS; BENZODIAZEPINONES; COCAINE; CONDITIONING (PSYCHOLOGY); INDOLES; LOCOMOTION; MALE; NUCLEUS ACCUMBENS; PHENYLUREA COMPOUNDS; RATS; RATS, WISTAR; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ;

EID: 0030843444     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00410-1     Document Type: Article

References (36)

1. R.J. Beninger, B.L. Hahn, Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning, Science 220 (1983) 1304-1306.
2. R.J. Beninger, R.S. Herz, Pimozide blocks establishment but not expression of cocaine-produced environment-specific conditioning, Life Sci. 38 (1986) 1425-1431.
3. D. Bindra, Neuropsychological interpretation of drive and incentive-motivation on general activity and instrumental behavior, Psychol. Rev. 75 (1968) 1-22.
4. J.N. Crawley, Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway, J. Neurosci. 12 (1992) 3380-3393.
5. A. De Weerth, J.R. Pisegna, K. Huppi, S.A. Wank, Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor, Biochem. Biophys. Res. Commun. 194 (1993) 811-818.
6. K.L. Drew, S.D. Glick, Role of D-1 and D-2 receptor stimulation in sensitization to amphetamine-induced circling behavior and in expression and extinction of the Pavlovian conditioned response, Psychopharmacology 101 (1990) 465-471.
7. P.C. Emson, J.F. Rehfeld, M.N. Rossor, Distribution of CCK-like peptides in the human brain, J. Neurochem. 38 (1982) 1177-1179.
8. D. Fontana, R.M. Post, S.R.B. Weiss, A. Pert, The role of D1 and D2 dopamine receptors in the acquisition and expression of cocaine-induced conditioned increases in locomotor behavior, Behav. Pharmacol. 4 (1993) 375-387.
9. G.A. Higgins, N. Joharchi, Y. Wang, W.A. Corrigall, E.M. Sellers, The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol, Brain Res. 640 (1994) 246-254.
10. G.A. Higgins, P. Nguyen, E.M. Sellers, Blockade of morphine place conditioning by the CCKA receptor antagonist devazepide, Eur. J. Pharmacol. 197 (1991) 229-230.
11. B receptor antagonists, Brain Res. 572 (1992) 208-215.
12. B receptor mechanisms to individual differences in amphetamine-induced locomotion, Pharmacol. Biochem. Behav. 48 (1994) 1019-1024.
13. T. Hökfelt, J.F. Rehfeld, L. Skirboll, B. Ivemark, M. Goldstein, K. Markey, Evidence of co-existence of dopamine and CCK in mesolimbic neurons, Nature 285 (1980) 476-478.
14. R.B. Innis, S.H. Snyder, Distinct cholecystokinin receptors in brain and pancreas, Proc. Natl. Acad. Sci. USA 77 (1980) 6917-6921.
15. S. Itoh, A. Takashima, Y. Maeda, Memory impairments induced by peripherally administered CCK-A type receptor antagonists in rats, Drug Dev. Res. 126 (1992) 89-99.
16. B receptors with amphetamine in responding for conditioned rewards, Peptides 16 (1995) 959-964.
17. A receptor antagonist, Pharmacol. Biochem. Behav. 55 (1996) 439-444.
18. B receptor antagonist, microinjected into the nucleus accumbens and the expression of conditioned rewarded behavior, Neurosci. Lett. 209 (1996) 85-88.
19. A antagonist, impairs the acquisition of conditioned reward and conditioned activity, Psychopharmacology 123 (1996) 131-143.
20. Keppel, G., Design and Analysis: A Researcher's Handbook, 2nd edn., Prentice-Hall Inc., Englewood Cliffs, NJ, 1982.
21. M. Lemaire, O. Piot, B.P. Roques, G.A. Bohme, J.C. Blanchard, Evidence for an endogenous cholecystokinergic balance in social memory, NeuroReport 3 (1992) 929-932.
22. B) ligand: L-365,260, Eur. J. Pharmacol. 162 (1989) 273-280.
23. F.H. Marshall, S. Barnes, J. Hughes, G.N. Woodruff, J.C. Hunter, Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms, J. Neurochem. 56 (1991) 917-922.
24. M.T. Martin-Iverson, D.J. McManus, Stimulant conditioned locomotion is not affected by blockade of D1 and/or D2 dopamine receptors during conditioning, Brain Res. 521 (1990) 175-184.
25. E.J. Mazurksi, R.J. Beninger, Environment-specific conditioning and sensitization with (+)-amphetamine, Pharmacol. Biochem. Behav. 27 (1987) 61-65.
26. E.J. Mazurski, R.J. Beninger, Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats, Psychopharmacology 105 (1991) 107-112.
27. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, Sydney, 1986.
28. G.D. Phillips, J. LeNoury, G. Wolterink, J. Donsellar-Wolterink, T.W. Robbins, B.J. Everitt, Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behavior by conditioned reinforcement, Behav. Brain Res. 55 (1993) 223-231.
29. B receptor agonists and antagonists, Mol. Neuropharmacol. 1 (1992) 211-218.
30. A.R. Reimer, M.T. Martin-Iverson, Nimodipine and haloperidol attenuate behavioral sensitization to cocaine but only nimodipine blocks the establishment of conditioned locomotion by cocaine, Psychopharmacology 113 (1994) 404-410.
31. H. Sankaran, I.D. Goldfine, C.W. Deveney, K.W. Wong, J.A. Williams, Binding of cholecystokinin to high affinity receptors on isolated pancreatic acini, J. Biol. Chem. 255 (1980) 18849-18853.
32. R.D. Spealman, Failure of cholecystokinin antagonists to modify the discriminative stimulus effects of cocaine, Pharmacol. Biochem. Behav. 43 (1992) 613-616.
33. A. Takashima, S. Itoh, Memory impairment produced by CCK-8 antagonists in passive avoidance response of rats, Drug Dev. Res. 18 (1989) 95-100.
34. F.J. Vaccarino, Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors, Neurosci. Biobehav. Rev. 18 (1994) 207-214.
35. J.J. Vanderhaegan, J.C. Signeau, W. Gepts, New peptide in the vertebrate CNS reacting with antigastrin antibodies, Nature 257 (1975) 604-605.
36. S.A. Wank, J.R. Pisegna, A. De Weerth, Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression, Proc. Natl. Acad. Sci. USA 89 (1992) 8670-8691.